People · Operator
Named in public records as an officer, director or promoter · active 2010–2016 · Biotechnology, Business Services
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Lab21 Ltd | — | Biotechnology | Pre-Seed | $838K | $46.3M | 2010 |
| Selah Genomics Inc. | — | Business Services | Pre-Seed | $750K | $14.2M | 2013 |
Michael S. Bolick at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael S. Bolick on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeremy S. Stuart | 1 | 1 |
| Kai T Deusch | 1 | 1 |
| Berwyn E Clarke | 1 | 1 |
| Anthony E Atkinson | 1 | 1 |
| Edwin T Snape | 1 | 1 |
| Christopher T Evans | 1 | 1 |
| Susan E Lowther | 1 | 1 |
| Graham D Mullis | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.